Literature DB >> 15894449

Stability of baicalin in biological fluids in vitro.

Jie Xing1, Xiaoyan Chen, Dafang Zhong.   

Abstract

The stability of baicalin in buffered aqueous solutions at different pHs and in biological fluids, including plasma, urine and tissue homogenates, were investigated in vitro. Structures of the degradation products of baicalin were elucidated by liquid chromatography-electrospray ion trap mass spectrometry and the degradation mechanism was proposed with the aid of electron paramagnetic resonance spectrometry. The results showed that the degradation of baicalin was pH- and temperature-dependent. The oxidation-reduction reaction intermediated by phenoxyl radicals is the major degradation process for baicalin in plasma and urine in vitro, whereas baicalin mainly undergoes hydrolysis and phase II metabolic pathways when spiked in tissue homogenates. It is found that acidification can stabilize baicalin in urine and plasma (the final pH adjusted to 3.0-4.0), and baicalin is relatively stable in tissues homogenized with methanol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15894449     DOI: 10.1016/j.jpba.2005.03.034

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.

Authors:  Jian-feng Xing; Hai-sheng You; Ya-lin Dong; Jun Lu; Si-ying Chen; Hui-fang Zhu; Qian Dong; Mao-yi Wang; Wei-hua Dong
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

2.  Overestimation of flavonoid aglycones as a result of the ex vivo deconjugation of glucuronides by the tissue β-glucuronidase.

Authors:  Qing-Yi Lu; Lifeng Zhang; Guido Eibl; Vay Liang W Go
Journal:  J Pharm Biomed Anal       Date:  2013-10-05       Impact factor: 3.935

3.  Detection of baicalin metabolites baicalein and oroxylin-a in mouse pancreas and pancreatic xenografts.

Authors:  Qing-Yi Lu; Lifeng Zhang; Aune Moro; Monica C Chen; Diane M Harris; Guido Eibl; Vay-Liang W Go
Journal:  Pancreas       Date:  2012-05       Impact factor: 3.327

4.  Iron-binding and anti-Fenton properties of baicalein and baicalin.

Authors:  Carlos A Perez; Yibin Wei; Maolin Guo
Journal:  J Inorg Biochem       Date:  2008-11-19       Impact factor: 4.155

5.  Comparative research on stability of baicalin and baicalein administrated in monomer and total flavonoid fraction form of Radix scutellariae in biological fluids in vitro.

Authors:  Zhiqiang Feng; Jie Zhou; Xueying Shang; Guojun Kuang; Jian Han; Liping Lu; Lei Zhang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

6.  Intravenous Administration of Scutellarin Nanoparticles Augments the Protective Effect against Cerebral Ischemia-Reperfusion Injury in Rats.

Authors:  Chang Yang; Qing Zhao; Shanshan Yang; Libin Wang; Xingyuan Xu; Lisu Li; Wafa T Al-Jamal
Journal:  Mol Pharm       Date:  2022-04-20       Impact factor: 5.364

7.  Comparative pharmacokinetics of baicalin and geniposide in juvenile and adult rats after oral administration of Qingkailing Granules.

Authors:  Ting-Yu Li; Zhong Li; Xiao-Yan Yang; Xin-Yu Zhao; Xu Zhang; Xin-Bo Zhao; Song Wang; Xiao-Kui Huo; Xiao-Ping Shi
Journal:  Chin Herb Med       Date:  2020-09-24

8.  HybridSPE: A novel technique to reduce phospholipid-based matrix effect in LC-ESI-MS Bioanalysis.

Authors:  Shafeeque Ahmad; Harsh Kalra; Amit Gupta; Bharat Raut; Arshad Hussain; Md Akhlaquer Rahman
Journal:  J Pharm Bioallied Sci       Date:  2012-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.